by Elec23 | Aug 23, 2024 | News&events
A new study suggests that antibodies produced by vaccinia-based vaccines may neutralize the Monkeypox virus, suggesting potential cross-protection against new threats. The findings emphasize VisMederi’s capability to aid in vaccine development and research...
by Elec23 | May 22, 2024 | News&events
The eighth edition of the “Influenza Vaccines for the World—IVW 2024” conference and exhibition is currently taking place in Siena (May 21–23, 2024). This event brings together world-renowned experts in the field of influenza vaccines and related issues...
by Elec23 | May 10, 2024 | News&events
VisMederi and the International Vaccine Institute have formed a new partnership to accelerate vaccine development in developing countries. VisMederi, a company at the forefront of research and innovation in the life sciences and biotechnology sectors, is pleased to...
by sara pugliese | Jan 24, 2016 | News&events
Prof. Emanuele Montomoli is joining the closure meeting of the Meningitis Vaccine Project (MVP) in Addis Abeb, Ethiopia, where is ongoing the Ministerial Conference on Immunization in Africa. MVP is a partnership between PATH and the World Health Organization promote...
